Investor profile
Columbus Venture Partners has backed 10 European tech companies across 12 funding rounds between 2017 and 2026, joining rounds totalling €341M. Most active in Healthtech and AI. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Ona Therapeutics | Spain | 1 | €74M |
| Arthex Biotech | Spain | 2 | €74M |
| Minoryx Therapeutics | Spain | 1 | €51M |
| Deepull | Spain | 1 | €50M |
| Vivet Therapeutics | France |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Ona Therapeutics | Series B | €74M | 2026-06 |
| Minoryx Therapeutics | Series C | €51M | 2022-05 |
| Deepull | Series C | €50M | 2025-04 |
| Arthex Biotech |
| 1 |
| €38M |
| Multiverse Computing | Spain | 1 | €25M |
| Highlight Therapeutics | Spain | 1 | €15M |
| Integra Therapeutics | Spain | 2 | €12M |
| Cocoon Bioscience | Spain | 1 | €2.0M |
| Visium | Switzerland | 1 | €0 |
| Series B |
| €42M |
| 2023-05 |
| Vivet Therapeutics | Series A | €38M | 2017-05 |
| Arthex Biotech | Series B | €32M | 2025-09 |
| Multiverse Computing | Other | €25M | 2024-03 |
| Highlight Therapeutics | Other | €15M | 2025-09 |
| Integra Therapeutics | Seed | €11M | 2025-09 |
| Cocoon Bioscience | Other | €2.0M | 2023-11 |
